Case Studies
U.S. Pharma Consulting (USPC) provides full regulatory and commercialization strategy, product launch excellence, and manufacturing optimization to help clients transform promising molecules into commercial success. We align regulatory, market access, commercialization, and launch execution with your business objectives to accelerate readiness, strengthen market position, and maximize long-term value. Please explore our Industry Insights and Case Studies.


Where AI-enabled biopharma workflows are gaining traction
Slide Deck
May 2026

Medical Device Quality System Alignment and Regulatory Readiness
Case Study
May 2026

JPM 2026 Signal: AI Is Moving from Talk to Transactions & CMS priorities around Drug-to-Drug interaction and patient safety
Case Study
April 2026

2026 Segment-Specific Industry Update Brand/Innovator Drugs, Generics, Biotech, Cell & Gene Therapy and PBM’s
Case Study
April 2026

AMR at the Crossroads: AI-Enabled Strategy for Antimicrobial Innovation, Access, and Commercial Sustainability
Case Study
March 2026

US Antibiotics: A U.S. Led Strategic Focus with Global Market Influence Repositioning a Core U.S.Asset as a Strategic Opportunity
Case Study
March 2026

How AI Aligns with Existing EHR Clinical Decision Support Rule Workflows - Part 1
Case Study
February 2026

AI Translating the Clinical and Economic Framework into a Realistic, Governance-Aligned Monetization Pathway - Part 2
Case Study
February 2026

AI will Functions not as a Diagnostic System or Alerting Overlay, but as a Utilization Management Enabler that Strengthens Existing Clinical and Regulatory Workflows - Part 3
Case Study
February 2026

AI is the Prescription Safety AI Connector Solution – Connecting all the Dots
Case Study
December 2025

Mission Critical 505 (b)(1) or (2) Product Launch Excellence & Value Proposition Workflow
Workflow Chart
November 2024

FDA Discovery, Development, Approval, Lifecycle Circle of Life
Workflow Chart
October 2024

Rapid Development, Implementation and U.S. Market Entry of a Telehealth, and Direct-to-Patient Business:
Case Study
May 2023

Antibiotic Manufacturer's Rapid U.S. Market Entry and Commercialization Expansion:
Case Study
May 2023
Hear what our clients have to say.
Connect with USPC today for your free consultation.
Let’s start a conversation.